| Name | Title | Contact Details |
|---|
Neuronetics, Inc. believes that mental health is as important as physical health. As a global leader in neuroscience, Neuronetics is redefining patient and physician expectations with its NeuroStar Advanced Therapy for Mental Health. NeuroStar is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions when traditional medication hasn`t helped. NeuroStar is FDA-cleared for adults with major depressive disorder (MDD), as an adjunct for adults with obsessive-compulsive disorder (OCD), and to decrease anxiety symptoms in adult patients with MDD that may exhibit comorbid anxiety symptoms (anxious depression). NeuroStar Advanced Therapy is the leading transcranial magnetic stimulation (TMS) treatment for MDD in adults with over 5 million treatments delivered. NeuroStar is backed by the largest clinical data set of any TMS system for depression, including the world`s largest depression Outcomes Registry. Neuronetics is committed to transforming lives by offering an exceptional treatment that produces extraordinary results.
Intellijoint Surgical develops and commercializes surgical navigation solutions for total joint replacements. We are committed to improving patients` lives by providing every surgeon with effective, easy-to-use technology.
Integra Radionics is a Burlington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Audiology Management Group, Inc. is an innovative practice development services company geared toward helping audiology and ENT practices throughout the country thrive and grow in today`s market.
Second Sight ® Medical Products, Inc., located in Sylmar, California, was founded in 1998 to create a retinal prosthesis to provide sight to patients blinded from outer retinal degenerations, such as Retinitis Pigmentosa.